Vanguard Health Care ETF (VHT)
| Assets | $17.06B |
| Expense Ratio | 0.10% |
| PE Ratio | 23.85 |
| Shares Out | 87.27M |
| Dividend (ttm) | $3.85 |
| Dividend Yield | 1.46% |
| Ex-Dividend Date | Sep 27, 2024 |
| Payout Ratio | 34.89% |
| 1-Year Return | +12.81% |
| Volume | 308,554 |
| Open | 260.78 |
| Previous Close | 260.25 |
| Day's Range | 260.10 - 263.30 |
| 52-Week Low | 235.39 |
| 52-Week High | 289.14 |
| Beta | 0.72 |
| Holdings | 416 |
| Inception Date | Jan 26, 2004 |
About VHT
Fund Home PageThe Vanguard Health Care ETF (VHT) is an exchange-traded fund that is based on the MSCI US IMI 25/50 Health Care indexThe fund tracks a market-cap-weighted index of US healthcare stocks VHT was launched on Jan 26, 2004 and is issued by Vanguard.
Top 10 Holdings
47.96% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 10.81% |
| UnitedHealth Group Incorporated | UNH | 8.38% |
| AbbVie Inc. | ABBV | 5.26% |
| Johnson & Johnson | JNJ | 4.69% |
| Merck & Co., Inc. | MRK | 3.99% |
| Thermo Fisher Scientific Inc. | TMO | 3.36% |
| Abbott Laboratories | ABT | 3.18% |
| Intuitive Surgical, Inc. | ISRG | 2.88% |
| Amgen Inc. | AMGN | 2.77% |
| Danaher Corporation | DHR | 2.64% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 27, 2024 | $1.167 | Oct 1, 2024 |
| Jun 28, 2024 | $0.966 | Jul 2, 2024 |
| Mar 22, 2024 | $0.819 | Mar 27, 2024 |
| Dec 19, 2023 | $0.895 | Dec 22, 2023 |
| Sep 28, 2023 | $0.877 | Oct 3, 2023 |
| Jun 29, 2023 | $0.877 | Jul 5, 2023 |
News
VHT Is Breaking Out On Healthcare Strength (Technical Analysis)
The healthcare industry shows consistent growth and resilience, driven by medical advancements and aging demographics, making long-term investing in healthcare sensible. VHT offers diversified exposur...
VHT: With Recession Risks Rising, It's Time To Play Defense With Healthcare
Vanguard Health Care ETF focuses on investing in successful healthcare companies with $20 billion in assets and a low expense ratio of 0.10%. Top holdings include Eli Lilly, UnitedHealth Group, and Jo...
VHT: A Cheap And Easy Way To Access Healthcare
The health care sector shows promising growth and potential for significant returns, dominated by GLP-1 weight loss hype. Vanguard Health Care Index Fund ETF Shares tracks the performance of the MSCI ...
VHT: Well-Positioned Fund In A Promising Sector, But Mediocre Compared To Peers
Vanguard's Health Care ETF has slightly underperformed peer healthcare funds and risks underperforming looking forward due to its current mix of holdings. VHT is broadly diversified, resulting in a lo...
Healthcare In 2024: Navigating The Biopharma Bull Run
The healthcare sector presents a unique investment opportunity in 2024 due to attractive valuation and uncorrelated/robust cashflow of healthcare. Biopharma companies have pricing power and ability to...
Catalyst Watch: Cigna, Humana Deal Would Face Regulatory Hurdles
Economists expect a rise of about 175,000 in non-farm payrolls. Broadcom and Lululemon are set to report earnings, with analysis focused on Broadcom's relationship with Google and Lululemon's success ...
VHT: Current Valuation Not Justified Due To Declining Long-Term Earnings Growth Forecast
VHT offers better downside protection than the broader market but its long-term earnings growth is in a declining trend. VHT's valuation is not attractive relative to the S&P 500 index. Valuation comp...
VHT: Overweight Health Care As It Makes Its Seasonal Dip
Health Care sector has shown recent relative strength in the last month after a poor start to the year versus the S&P 500. Vanguard Health Care sector ETF is recommended with low expense ratio and sol...
XLV Vs. VHT: A Head-To-Head Healthcare ETF Comparison
The Health Care Select Sector SPDR ETF and the Vanguard Health Care ETF are the two most popular Health Care ETFs, with a combined $57 billion in assets under management. Both ETFs have a 0.10% expens...
VHT: Why Vanguard's Healthcare ETF Outperformed Last Week
Vanguard's cost-efficient (0.10% expense fee) Health Care ETF is an excellent defensively-oriented fund to hold during challenging economic times. That being the case, the VHT ETF significantly outper...
Vanguard ETFs: Recommendations For 2023
Expert recommendations for choosing among the myriad of Vanguard ETFs may prove to be a valuable resource to investors, even if not all of them will prove right. I present such recommendations made by...
ETFs Concealing Billions of Dollars of Insider Trades
Shadow trades using ETFs targeting U.S. companies totaled $360 million per year in the six years up to 2020.
VHT: You Won't Get Defensive Healthcare Exposure Here
Healthcare is considered a defensive sector and due to the brand name and cheap exposure, Vanguard's ETF prima-facie looks like a promising idea. However, outsized exposure to pharmaceuticals and biot...
VHT: 2 Megatrends In Healthcare
An aging population is expected to boost the demand for healthcare over the next few decades. The potential to reduce time and cost using AI in healthcare is an absolute game changer for the industry.
14 High-Yield Blue-Chips Perfect For 2023
The first few months of 2023 could see stocks fall 10% to 23%, and a lot of investors could make disastrous mistakes. Low-volatility high-yield blue-chips are a great way to stay invested and profit f...
VHT Vs. XLV: Picking A Winner In The Health Care Sector
In August, I wrote an article entitled The World Of 4,818 Faces An Uncertain Future. In such an environment, I believe the Health Care sector is worthy of your consideration. In this article, I draw f...
2 Dividend Blue-Chips Perfect For 2023
Most investors, economists, CEOs, and the bond market are confident a recession is coming in 2023. That means potentially another 15% to 20% downside risk for the market. Consumer staples, healthcare,...
How I Built A $3 Million High-Yield Portfolio With 11 Blue-Chips
Putting new money to work in a bear market can be terrifying, whether you have $3,000 or $3 million. But history is clear that buying blue-chip bargains in a bear market can make you rich.
What The Inflation Reduction Act Means For Drug Prices
The recently enacted Inflation Reduction Act looks to rein in prescription drug prices and could impact the pharma industry's long-term financial performance. The legislation caps out-of-pocket costs ...
Inflation Reduction Act: VHT Should Be OK, But Amgen Can Fair Better
The healthcare sector has been under pressure for years as lawmakers have been trying to curb the escalation of pharmaceutical prices. The recent signing of the Inflation Reduction Act marks a major m...
Vanguard Health Care ETF: Healthcare Exposure Benefits
Since the beginning of the year, the healthcare sector has recorded a -8.14% loss compared to the S&P 500's -12.63%. VHT currently charges a 0.10% expense ratio and pays a 1.30% dividend yield.
Pharma market investments: How ETFs help you dabble in the sector at a modest price
Some health care sector ETFs have exposure to companies like Johnson & Johnson, Pfizer, UnitedHealth